1 |
Scott SN, Boeve TJ, McCulloch TM, et al. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope 2002;112(7 Pt 1):1221-9.
DOI
|
2 |
Weber RS, Jabbour N, Martin RC 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008;15:34-45.
DOI
|
3 |
Lynn S, McDaniel J. Managing severe anemia when the patient is a Jehovah's Witness. JAAPA 2013;26:24-9.
DOI
|
4 |
Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev 2013;27:221-34.
DOI
|
5 |
Bacuzzi A, Dionigi G, Piffaretti G, et al. Preoperative methods to improve erythropoiesis. Transplant Proc 2011;43: 324-6.
DOI
|
6 |
Dixon JL, Smalley MG. Jehovah's Witnesses: the surgical/ethical challenge. JAMA 1981;246:2471-2.
DOI
|
7 |
Ball AM, Winstead PS. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. Pharmacotherapy 2008;28:1383-90.
DOI
|
8 |
Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 2008;358:784-93.
DOI
|
9 |
Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010;18:132-8.
DOI
|
10 |
Shander A. Acute normovolemic hemodilution (ANH): a practical approach. Transfus Altern Transfus Med 1999;1:7-10.
DOI
|
11 |
Marsh JC, Bevan DH. Haematological care of the Jehovah's Witness patient. Br J Haematol 2002;119:25-37.
DOI
|
12 |
Kretschmer W, Koster U, Dietz K, et al. Factors for intraoperative blood loss in bimaxillary osteotomies. J Oral Maxillofac Surg 2008;66:1399-403.
DOI
|
13 |
Sowade O, Warnke H, Scigalla P. Operations with a heart-lung machine in adult members of Jehovah's Witnesses. Anaesthesist 1995;44:257-64.
DOI
|
14 |
Suess S, Suess O, Brock M. Neurosurgical procedures in Jehovah's Witnesses: an increased risk? Neurosurgery 2001;49:266-73.
DOI
|
15 |
Wittmann PH, Wittmann FW. Total hip replacement surgery without blood transfusion in Jehovah's Witnesses. Br J Anaesth 1992;68:306-7.
DOI
|
16 |
Li KK, Meara JG, Alexander A Jr. Location of the descending palatine artery in relation to the Le Fort I osteotomy. J Oral Maxillofac Surg 1996;54:822-7.
DOI
|
17 |
Lanigan DT, Hey JH, West RA. Major vascular complications of orthognathic surgery: hemorrhage associated with Le Fort I osteotomies. J Oral Maxillofac Surg 1990;48:561-73.
DOI
|
18 |
Pineiro-Aguilar A, Somoza-Martin M, Gandara-Rey JM, et al. Blood loss in orthognathic surgery: a systematic review. J Oral Maxillofac Surg 2011;69:885-92.
DOI
|
19 |
Ueki K, Marukawa K, Shimada M, et al. The assessment of blood loss in orthognathic surgery for prognathia. J Oral Maxillofac Surg 2005;63:350-4.
DOI
|
20 |
Thastum M, Andersen K, Rude K, et al. Factors influencing intraoperative blood loss in orthognathic surgery. Int J Oral Maxillofac Surg 2016;45:1070-3.
DOI
|
21 |
Choi WS, Irwin MG, Samman N. The effect of tranexamic acid on blood loss during orthognathic surgery: a randomized controlled trial. J Oral Maxillofac Surg 2009;67:125-33.
DOI
|
22 |
Olsen JJ, Skov J, Ingerslev J, et al. Prevention of bleeding in orthognathic surgery: a systematic review and meta-analysis of randomized controlled trials. J Oral Maxillofac Surg 2016;74:139-50.
DOI
|
23 |
Madsen DE, Ingerslev J, Sidelmann JJ, et al. Intraoperative blood loss during orthognathic surgery is predicted by thromboelastography. J Oral Maxillofac Surg 2012;70:e547-52.
DOI
|
24 |
Shander A, Javidroozi M. The approach to patients with bleeding disorders who do not accept blood-derived products. Semin Thromb Hemost 2013;39:182-90.
DOI
|